Nika Pharmaceuticals, Inc. (NIKA)

OTCMKTS · Delayed Price · Currency is USD
0.507
+0.331 (188.02%)
At close: Nov 22, 2024
-96.37%
Market Cap 516.61M
Revenue (ttm) n/a
Net Income (ttm) -90.65K
Shares Out 1.02B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Open 0.590
Previous Close 0.176
Day's Range 0.507 - 0.590
52-Week Range 0.030 - 13.990
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 12, 2025

About Nika Pharmaceuticals

Nika Pharmaceuticals, Inc. engages in the development and distribution of various pharmaceutical products. It develops dietary supplements and antiviral drugs; and thymus nuclear glycoprotein (TNG) for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada. [Read more]

Sector Healthcare
Founded 2000
Country United States
Stock Exchange OTCMKTS
Ticker Symbol NIKA
Full Company Profile

Financial Performance

Financial Statements

News

Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria

Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.

6 months ago - GlobeNewsWire

Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy

HENDERSON, Nev., June 03, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) introduces its plans to develop the company into a sustainable business project that will consistently gro...

7 months ago - GlobeNewsWire

Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building

HENDERSON, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces that it is the beneficial owner of a production building and land valued at $2,045,209, located i...

8 months ago - GlobeNewsWire

Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building

HENDERSON, Nev., May 10, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces that it is the beneficial owner of a production building and land valued at $2,045,209, located i...

8 months ago - GlobeNewsWire